Notably, analyses of tumor biopsy lysates showed that SMYD3 expression is higher in TKO-mutant mice treated with CP compared with naïve tumor samples (Supplementary Fig. S7F), suggesting that increased SMYD3 expression correlates with prolonged exposure to CP. Here, SMYD3 is linked to neoplasm.